Recombinant Human ADRa1A Protein，His

ADRa1A, or alpha-1A adrenergic receptor, is a G protein-coupled receptor that plays a crucial role in various physiological processes, including smooth muscle contraction, neurotransmitter release, and cardiovascular function. Research on ADRa1A is particularly significant due to its involvement in several pathological conditions, such as hypertension, heart failure, and prostate disorders. The receptor is primarily activated by catecholamines, leading to a cascade of intracellular signaling pathways that impact vascular tone and blood pressure regulation. Understanding the structure and function of ADRa1A through recombinant protein studies has become a pivotal area of research, as it aids in elucidating the receptor's mechanisms and potential drug interactions. By employing techniques such as molecular cloning, protein expression, and purification, scientists can generate recombinant ADRa1A proteins to study their binding affinities and functional responses to various ligands. This research not only contributes to basic scientific knowledge but also opens up avenues for developing targeted therapies that can modulate ADRa1A activity, offering new treatment options for conditions related to adrenergic signaling dysregulation. Overall, the investigation of ADRa1A recombinant proteins enhances our understanding of adrenergic signaling in health and disease, underscoring its potential as a therapeutic target in pharmacology.